Photooxidation of lens α-crystallin by hypericin (active ingredient in St John's Wort)

被引:0
|
作者
Schey, KL
Patat, S
Chignell, CF
Datillo, M
Wang, RH
Roberts, JE
机构
[1] Fordham Univ, New York, NY 10023 USA
[2] Med Univ S Carolina, Dept Cell & Mol Pharmacol & Expt Therapeut, Charleston, SC 29425 USA
[3] Natl Inst Environm Hlth Sci, Res Triangle Pk, NC USA
关键词
D O I
10.1562/0031-8655(2000)072<0200:POLCBH>2.0.CO;2
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Hypericin is the active ingredient in the over the counter antidepressant medication St. John's Wort. Hypericin produces singlet oxygen and other excited state intermediates that indicate it should be a very efficient phototoxic agent in the eye. Furthermore it absorbs in the UV and visible range, which means it can potentially damage both the lens and the retina. Lens a-crystallin, isolated from calf lenses, was irradiated in the presence of hypericin (5 x 10(-5) M, 10 mM ammonium bicarbonate, pH 7.0) and in the presence and absence of light (>300 nm, 24 mW/cm(2)). Hypericin-induced photosensitized photopolymerization as assessed by sodium dodecylsulfate-polyacrylamide gel electrophoresis, Further analysis of the oxidative changes occurring in cw-crystallin using mass spectrometry showed specific oxidation of methionine, tryptophan and histidine residues, which increased with irradiation time. Hypericin did not damage the lens protein in the dark. Damage to cu-crystallin could undermine the integrity of the lens directly by protein denaturation and indirectly by disturbing chaperone function. Therefore, in the presence of light, hypericin can induce changes in lens protein that could lead to the formation of cataracts. Appropriate precautions should be taken to protect the eye from intense sunlight while on this antidepressant medication.
引用
收藏
页码:200 / 203
页数:4
相关论文
共 50 条
  • [41] St. John's wort for depression
    Moore, KL
    HEADACHE QUARTERLY-CURRENT TREATMENT AND RESEARCH, 1998, 9 (04): : 319 - 320
  • [42] St. John's wort for depression
    Malaty, W
    AMERICAN FAMILY PHYSICIAN, 2005, 71 (07) : 1375 - 1376
  • [43] Erythroderma associated with St John's wort
    Holme, SA
    Roberts, DL
    BRITISH JOURNAL OF DERMATOLOGY, 2000, 143 (05) : 1127 - 1128
  • [44] Hepatoprotective effect of St John's Wort
    Herekman-Demir, T.
    Ozturk, N.
    Ozturk, Y.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2001, 15 : 104 - 104
  • [45] St. John's wort and schizophrenia
    Lal, S
    Iskandar, H
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2000, 163 (03) : 262 - 263
  • [46] St John's wort (Hypericum perforatum)
    Barnes, Joanne
    JOURNAL OF PRIMARY HEALTH CARE, 2009, 1 (01) : 65 - 65
  • [47] Control of St John's wort in Australia
    Imms, AD
    NATURE, 1944, 153 : 785 - 785
  • [48] St John's wort and major depression
    Fugh-Berman, A
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (01): : 43 - 44
  • [49] St John's wort during pregnancy
    Grush, LR
    Nierenberg, A
    Keefe, B
    Cohen, LS
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (18): : 1566 - 1566
  • [50] St. John's wort and depression
    Michel, ML
    AMERICAN JOURNAL OF NURSING, 1998, 98 (04) : 66 - 66